期刊文献+

靶向mdr1b/mdr1a基因siRNA逆转T24/ADM多药耐药性研究 被引量:2

Effect of mdr1b/mdr1a siRNA on multidrug resistance of bladder carcinoma cell line T24/ADM
下载PDF
导出
摘要 目的:研究mdr1b/a基因siRNA(small interfering RNA)逆转膀胱癌的多药耐药性。方法:设计mdr1b/a基因的siRNA,转染膀胱癌T24/ADM细胞,用RT-PCR分析mRNA的表达,Rh123分析P-gp活性,流式细胞仪检测细胞内阿霉素积累量。结果:siRNA能明显地逆转T24/ADM细胞的多药耐药,使mdr1b/a基因的mRNA表达水平下调,细胞内阿霉素积累量显著增加(P<0.05)。结论:mdr1b/a基因siRNA能够逆转膀胱癌的多药耐药性。 Objective: To investigate the effect of mdrlb/mdrla siRNA on multidrug resistance of bladder carcinoma cell line T24/ADM. Methods: The proper mdrlb/a siRNA was designed, synthesized and transfected into bladder carcinoma cell line T24/ADM. Expression level of mdrlb/a mRNA was deter- mined by PCR. The activity of Pgp was measured by Rhodamine 123 efflux assay, The intracellular accumulation of ADM was assayed with flow cytometry. Results: After treated with siRNA, the expression level of mdrlb/ was increased si ante of bladder a mRNA in T24/ADM decreased obviously, and the intracellular accumulation of ADM gnificantly (P〈0.05). Conclusions: The mdrlb/asiRNA can reverse the multidrug resist- carcinoma cell line T24/ADM.
出处 《海南医学院学报》 CAS 2012年第7期865-868,共4页 Journal of Hainan Medical University
基金 湖北省教育厅科学技术研究计划重点项目(D20082404)~~
关键词 SIRNA mdr1b/a基因 多药耐药 膀胱癌 siRNA mdrlb/a gene Multidrug resistancel Bladder carcinoma cell
  • 相关文献

参考文献20

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics[J]. CA Cancer J Clin ,2002,2005(55):74.
  • 2Gottesman MM. Mechanisms of cancer drug resistance [J]. Annu Rev Med, 2002, 53:615-627.
  • 3Choi CH. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal[J]. Cancer Cell Int,2005, 5:30.
  • 4Ullah MF. Cancer multidrug resistance (MDR): A major impediment to effective chemotherapy[J]. Asian Pacific J Cancer Prey, 2008, 9 : 1-6.
  • 5Honjo K, Takahashi KA, Mazda O,et al. MDR1a/1b gene silencing enhances drug sensitivity in rat fibroblast- like synoviocytes[J]. J Gene Med ,2010, 12:219-227.
  • 6Zhang F, Riley J, Gant TW. Intrinsic multidrug class 1 and 2 gene expression and localization in rat and human mammary tumors[J]. Lab Invest, 1996, 75:413-426.
  • 7Borst P, Jonkers J, Rottenberg S. What makes tumors multidrug resistant? [J]. Cell Cycle, 2007, 6: 2782- 2787.
  • 8Ralph GS, Radeliffe PA, Day DM, et al. Silencing mutant SOD1 using RNAi protects against neurodegenera- tion and extends survival in an ALS model[J]. Nat Med,2005, 11:429-433.
  • 9Nakamura H, Siddiqui SS, Shen X, et al. RNA interference targeting transforming growth factor-beta type Ⅱ receptor suppresses ocular inflammation and fibrosis [J]. Mol Vis, 2004,4:703-711.
  • 10Ponnappa BC. siRNA for inflammatory diseases[J]. Curr Opin Investig Drugs, 2009, 10:418-424.

同被引文献26

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部